179 related articles for article (PubMed ID: 17652955)
1. p53 Mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection.
Kobayashi M; Kawachi H; Takizawa T; Uchida K; Sekine M; Kumagai J; Momma K; Nemoto T; Akashi T; Funata N; Eishi Y; Koike M
Oncology; 2006; 71(3-4):237-45. PubMed ID: 17652955
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
3. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
4. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
[TBL] [Abstract][Full Text] [Related]
5. p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China.
Wang LD; Zhou Q; Hong JY; Qiu SL; Yang CS
Cancer; 1996 Apr; 77(7):1244-9. PubMed ID: 8608498
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
[TBL] [Abstract][Full Text] [Related]
7. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.
van Sandick JW; Baak JP; van Lanschot JJ; Polkowski W; ten Kate FJ; Obertop H; Offerhaus GJ
J Pathol; 2000 Feb; 190(2):177-83. PubMed ID: 10657016
[TBL] [Abstract][Full Text] [Related]
8. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
9. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.
Weston AP; Banerjee SK; Sharma P; Tran TM; Richards R; Cherian R
Am J Gastroenterol; 2001 May; 96(5):1355-62. PubMed ID: 11374668
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus.
Bektas N; Donner A; Wirtz C; Heep H; Gabbert HE; Sarbia M
Am J Clin Pathol; 2000 Dec; 114(6):890-5. PubMed ID: 11338478
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of p53 gene mutation in esophageal exfoliative cells].
Kou YL; Zhang JR; Zhou Q; Zhao YF; Chen GD
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):349-52. PubMed ID: 15312345
[TBL] [Abstract][Full Text] [Related]
12. [Abnormal expression of p53, Ki67 and iNOS in human esophageal carcinoma in situ and pre-malignant lesions].
Jin Y; Zhang W; Liu B
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):129-31. PubMed ID: 11783017
[TBL] [Abstract][Full Text] [Related]
13. [Mutation of p53 gene in esophageal precancerous cells].
Kou Y; Zhang J; Chen G; Wu Z; Yang J; Jiang G; Zhao Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):306-9. PubMed ID: 12947722
[TBL] [Abstract][Full Text] [Related]
14. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
Chung SM; Kao J; Hyjek E; Chen YT
Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662
[TBL] [Abstract][Full Text] [Related]
15. [Expression of p53 in human esophageal carcinoma and pre-malignant lesions in the esophagus].
Dong Y; Liu S
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):58-60. PubMed ID: 8732116
[TBL] [Abstract][Full Text] [Related]
16. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation.
Polkowski W; Baak JP; van Lanschot JJ; Meijer GA; Schuurmans LT; Ten Kate FJ; Obertop H; Offerhaus GJ
J Pathol; 1998 Feb; 184(2):161-8. PubMed ID: 9602707
[TBL] [Abstract][Full Text] [Related]
17. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis.
Yasuda M; Kuwano H; Watanabe M; Toh Y; Ohno S; Sugimachi K
Br J Cancer; 2000 Oct; 83(8):1033-8. PubMed ID: 10993651
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.
Skacel M; Petras RE; Rybicki LA; Gramlich TL; Richter JE; Falk GW; Goldblum JR
Am J Gastroenterol; 2002 Oct; 97(10):2508-13. PubMed ID: 12385431
[TBL] [Abstract][Full Text] [Related]
20. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.
Yoshida T; Mikami T; Mitomi H; Okayasu I
J Pathol; 2003 Feb; 199(2):166-75. PubMed ID: 12533829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
